Clinical Trial Update: A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating REGENECYTE (human umbilical cord blood infusion) for individuals with Post-COVID Condition/Long COVID; the study status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-covid Condition

Drugs mentioned

• REGENECYTE (umbilical cord blood infusion)

Snippet

Sponsor: StemCyte, Inc. | Conditions: Long COVID, Post-COVID-19 Condition | Phase 3 | Status: NOT_YET_RECRUITING